Abstract:Purpose: Lamotrigine (LTG) is one of the most used antiseizure medications (ASMs). Titration is indicated for incomplete seizure control, but toxicity with vertigo, ataxia, and diplopia may ensue. Lamotrigine concentration would be the optimal diagnostic test. However, patients often receive a stroke evaluation when presenting to the emergency department (ED), leading to unnecessary cost and delayed management. We investigated the frequency of stroke evaluation for symptoms associated with LTG toxicity and attempted to identify factors leading to this expensive evaluation. Methods: We identified adult patients treated with LTG who presented to an emergency room with dizziness, ataxia, or diplopia and received a negative stroke evaluation, between 2003 and 2018. They were among 972 patients treated with LTG for epilepsy. We collected age at time of occurrence, symptoms presented, imaging studies performed, LTG dose and serum concentration, and the time the result was available. As a denominator, we also identified patients who developed clinical LTG toxicity during the same time period. Results: Thirteen patients with LTG toxicity had 16 negative stroke evaluations in the emergency room. Their mean age was 62 years (range: 43-79) as compared with 47 years for all patients treated with LTG (p < 0.0005). The mean daily LTG dose was 621 mg (range: 300-900 mg). A LTG serum concentration was requested on the day of evaluation in 7 instances, though the result was never available until at least the next day. In 4 instances, the LTG level was drawn 1-3 days after presentation. Five of the patients in this group were among 71 patients with clinical LTG toxicity and LTG concentration >20. Conclusion: Emergency departments will frequently call a stroke alert for patients taking LTG and presenting with symptoms consistent with LTG toxicity, particularly in seniors at greater risk of stroke. This adds not only expense but also radiation and contrast exposure from computed tomography (CT) studies. We recommend that a rapid LTG assay be made available and always ordered in patients receiving LTG, avoiding the considerable expense of an unnecessary stroke evaluation.

The Roller Coaster of Lamotrigine Levels: Successful Treatment of Massive Lamotrigine Overdose With Continuous Veno-Venous Hemodiafiltration and Rifampin

Data on the relationship between lamotrigine and levetiracetam serum/plasma levels and toxicity: Experience at an academic medical center

Delirium Secondary to Lamotrigine Toxicity

A Rare Case of Hemodialysis as an Extracorporeal Treatment for Severe Phenytoin Overdose

The Efficacy of Lamotrigine after Failure of the First Administration of Valproate in Treating Epilepsy: a Systematic Review and Meta-Analysis

Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy

Severe Acute Valproic Acid Intoxication Successfully Treated with Liver Support Therapy

Anticonvulsant Agents for Treatment of Restless Legs Syndrome: A Case Report With Lamotrigine and a Review of the Literature

Effectiveness of Lamotrigine in Maintaining Symptom Control in Pediatric Bipolar Disorder

Use of Iatrogenic Lipid Emulsion and Subsequent Plasmapheresis for the Treatment of Amitriptyline Overdose

Misdiagnosis of lamotrigine toxicity as posterior circulation transient ischemic attack or stroke

Lamotrigine Monotherapy for Paroxysmal Kinesigenic Dyskinesia in Children

Anticonvulsant Agents for Treatment of Restless Legs Syndrome

Combined Hemoperfusion and Continuous Veno-Venous Hemofiltration for Carbamazepine Intoxication

Lamotrigine Adjunctive Therapy To Lithium And Divalproex In Depressed Patients With Rapid Cycling Bipolar Disorder And A Recent Substance Use Disorder: A 12-Week, Double-Blind, Placebo-Controlled Pilot Study

Antimyoclonic and neuroprotective effects of lamotrigine in an animal model of cardiac arrest

The efficacy of lamotrigine in bipolar disorder: A systematic review and meta‐analysis

An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of lamotrigine in human serum and plasma

P10: Possible Lamotrigine-Induced Mania in a patient Epilepsy and perictal psychotic symptoms

Rescue strategies for valproic acid overdose poisoning: Case series and literature review

Neuroprotection of Lamotrigine on Hypoxic-Ischemic Brain Damage in Neonatal Rats: Relations to Administration Time and Doses.